- Home
- AENT vs NGEN Comparison
AENT vs NGEN Comparison
Compare AENT & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AENT | NGEN |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | United States | Canada |
| Employees | 697 | N/A |
| Industry | Durable Goods | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.4M | 317.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AENT | NGEN |
|---|---|---|
| Price | $6.91 | $3.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 116.7K | 94.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.44 | N/A |
| Revenue Next Year | $1.64 | N/A |
| P/E Ratio | $11.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.21 | $3.73 |
| 52 Week High | $8.80 | $5.93 |
Technical Indicators
Market Signals| Indicator | AENT | NGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.38 | 32.70 |
| Support Level | $6.93 | N/A |
| Resistance Level | $7.42 | $4.44 |
| Average True Range (ATR) | 0.65 | 0.27 |
| MACD | 0.21 | -0.01 |
| Stochastic Oscillator | 79.42 | 5.36 |
Price Performance
Historical ComparisonAbout AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world. The company has two divisions: Alliance Home Entertainment, which offers full-service support across production, marketing, and retail execution. and Alliance Authentic, which focuses on licensed collectibles and branded merchandise, including partnerships with Handmade by Robots, Master Replicas, and Weta Workshop.
About NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.